NextGen Healthcare Selected by Elite DNA to Improve Patient and Staff Experiences NextGen Healthcare, a top provider of innovative healthcare technology, has been selected by Elite DNA Behavioral Health, based…
Phase 2 Trial Begins for Early Alzheimer’s with Sinaptica’s Neuromodulation System Sinaptica Therapeutics, Inc., a clinical-stage company focused on developing personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has…
DIA Europe 2025 to Tackle EU Reforms & Global Healthcare Harmonization DIA, a global non-profit for life sciences professionals, will host DIA Europe 2025 from March 18-20 in Basel, bringing…
DocGo Expands into Chattanooga Region in Collaboration with Major Tennessee Healthcare System DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced…
ClearNote Health’s Avantect® Pancreatic Cancer Test Approved in New York ClearNote Health has received approval from the New York State Department of Health’s Clinical Laboratory Evaluation Program (CLEP) for its…
XRHealth Acquires RealizedCare, Expanding to Largest AI-Driven Therapeutic XR Platform XRHealth, a leader in therapeutic virtual reality (VR), mixed reality (MR), and extended reality (XR) solutions, has acquired the immersive…
Galderma’s Nemluvio® (Nemolizumab) Approved for Atopic Dermatitis and Prurigo Nodularis in the UK and Switzerland Galderma has announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) and…
CancerX Unveils 2025 Accelerator to Propel Oncology Innovation CancerX, a public-private partnership aimed at accelerating cancer innovation, has announced the launch of its 2025 Accelerator cohort. This year’s group includes…
Pneuma Respiratory Enhances Inhaled Therapies for Better Respiratory Health Pneuma Respiratory, a leading med-tech and pharmaceutical company, is pioneering innovative solutions in inhaled respiratory therapeutics aimed at transforming respiratory care.…
UK’s EDX Medical Develops New ‘Super Test’ for Prostate Cancer Scientists in Cambridge have created a groundbreaking new ‘super test’ for prostate cancer, aiming to transform the way the disease…
Cancer Breakthroughs: Veracyte’s Decipher Tests and GRID Tool at ASCO GU Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that new data presented at the 2025 ASCO…
OrthoNebraska Chooses Health Catalyst Ignite™ for Data-Driven Care Health Catalyst, Inc. (Nasdaq: HCAT), a leader in data and analytics technology for healthcare organizations, has announced a multi-year partnership with OrthoNebraska,…